Skip to main content

McKesson Value Stock - Dividend - Research Selection

Mckesson

ISIN: US58155Q1031 , WKN: 893953

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks in North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. This segment serves retail national accounts, including national and regional chains, food/drug combinations, mail order pharmacies, and mass merchandisers; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as offers its services to pharmaceutical manufacturers. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


BofA Lowers McKesson (MCK) Price Target, Flags GLP-1 Pricing Pressure

2026-04-07
McKesson Corporation (NYSE:MCK) is included among the 15 Best Consistent Dividend Stocks to Buy Right Now. On April 6, BofA analyst Allen Lutz lowered the firm’s price recommendation on McKesson Corporation (NYSE:MCK) to $1,000 from $1,040. It reiterated a Buy rating on the shares. The analyst said the rapid decline in cash-pay GLP-1 prices is […]

Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report?

2026-04-07
McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

2026-04-07
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

McKesson Corp. stock underperforms Monday when compared to competitors

2026-04-06
McKesson Corp. stock underperforms Monday when compared to competitors

Monday's session: gap up and gap down stock in the S&P500 index

2026-04-06
Stay tuned for the market movements in the S&P500 index on Monday. Check out the gap up and gap down stocks in the S&P500 index during today's session.

The Oncology Institute Names Minh Merchant Chief Legal Officer

2026-04-06
CERRITOS, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Minh Merchant has joined the organization as Chief Legal Officer. In this role, Ms. Merchant will oversee legal, regulatory, compliance and privacy functions as TOI continues to scale. This role will be essential in enabling the company to continue its growth trajectory while further enhancing its missio

Is Medline Inc. (MDLN) A Good Stock To Buy Now?

2026-04-06
Is MDLN a good stock to buy? We came across a bullish thesis on Medline Inc. on The Pursuit of Compounding’s Substack. In this article, we will summarize the bulls’ thesis on MDLN. Medline Inc.’s share was trading at $41.36 as of March 27th. MDLN’s trailing and forward P/E were 29.91 and 29.24 respectively according to Yahoo Finance. Medline Industries (MDLN) […]

B of A Securities Maintains Buy on McKesson, Lowers Price Target to $1000

2026-04-06
B of A Securities analyst Michael Cherny maintains McKesson (NYSE:MCK) with a Buy and lowers the price target from $1040 to $1000.

Gavin Newsom Hails Apple's '50 Years Of Innovation' As Tesla, Chevron, McKesson Leave California

2026-04-04
On Wednesday, Gov. Gavin Newsom (D-Calif.) praised Apple Inc. on its 50th anniversary, highlighting the company's innovation and resilience as other major corporations continue to leave the state. Apple's Half-Century Milestone On April 1, 2026, Apple celebrated 50 years since Steve Jobs and Steve Wozniak launched the company from a California garage in 1976. "For 50 years, @Apple has embodied and exemplified the best of California: ‘thinking different,' boldly innovating, and empowering people

Should Upgraded EPS Forecasts and Revenue Momentum Require Action From McKesson (MCK) Investors?

2026-04-03
In recent days, analysts have raised earnings estimates for McKesson, highlighting its consistent outperformance versus consensus EPS expectations and pointing to continued revenue expansion in pharmaceutical distribution. This wave of positive revisions underscores how McKesson’s execution in its core distribution business is influencing perceptions of its longer-term earnings power. We’ll now examine how these upgraded earnings expectations and McKesson’s consistent EPS outperformance...